A recent study from the Indian Institute of Science (IISc) has shed light on how this glucose traffic management goes wrong in Type 2 Diabetes (T2D), offering exciting new possibilities for treatment.

In a series of studies, researchers from India, UK and Australia, have provided an up-to-date account of the growing epidemic of type 2 diabetes, its prevalent clinical care, and the challenges faced by the public health system challenges in the countries of Bangladesh, Bhutan, India, Nepal, Pakistan, and Sri Lanka.